- Home
- LDWY vs TNON Comparison
LDWY vs TNON Comparison
Compare LDWY & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDWY
- TNON
- Stock Information
- Founded
- LDWY 1990
- TNON 2012
- Country
- LDWY United States
- TNON United States
- Employees
- LDWY N/A
- TNON 27
- Industry
- LDWY Advertising
- TNON Medical Specialities
- Sector
- LDWY Consumer Discretionary
- TNON Health Care
- Exchange
- LDWY Nasdaq
- TNON Nasdaq
- Market Cap
- LDWY 6.9M
- TNON 6.9M
- IPO Year
- LDWY 1991
- TNON 2022
- Fundamental
- Price
- LDWY $4.27
- TNON $1.11
- Analyst Decision
- LDWY
- TNON Strong Buy
- Analyst Count
- LDWY 0
- TNON 3
- Target Price
- LDWY N/A
- TNON $11.67
- AVG Volume (30 Days)
- LDWY 6.2K
- TNON 384.4K
- Earning Date
- LDWY 05-13-2025
- TNON 05-13-2025
- Dividend Yield
- LDWY N/A
- TNON N/A
- EPS Growth
- LDWY N/A
- TNON N/A
- EPS
- LDWY N/A
- TNON N/A
- Revenue
- LDWY $42,183,000.00
- TNON $3,284,000.00
- Revenue This Year
- LDWY N/A
- TNON $92.25
- Revenue Next Year
- LDWY N/A
- TNON $29.65
- P/E Ratio
- LDWY N/A
- TNON N/A
- Revenue Growth
- LDWY 425.12
- TNON 2.18
- 52 Week Low
- LDWY $3.02
- TNON $0.91
- 52 Week High
- LDWY $5.88
- TNON $15.79
- Technical
- Relative Strength Index (RSI)
- LDWY 62.01
- TNON 45.22
- Support Level
- LDWY $3.83
- TNON $1.08
- Resistance Level
- LDWY $4.49
- TNON $1.35
- Average True Range (ATR)
- LDWY 0.16
- TNON 0.07
- MACD
- LDWY 0.03
- TNON 0.01
- Stochastic Oscillator
- LDWY 68.53
- TNON 17.24
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two industries: Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.